Waterfront Wealth Inc. Charles River Laboratories International, Inc. Transaction History
Waterfront Wealth Inc.
- $389 Million
- Q4 2024
A detailed history of Waterfront Wealth Inc. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Waterfront Wealth Inc. holds 3,485 shares of CRL stock, worth $568,473. This represents 0.17% of its overall portfolio holdings.
Number of Shares
3,485
Previous 3,795
8.17%
Holding current value
$568,473
Previous $747,000
13.92%
% of portfolio
0.17%
Previous 0.19%
Shares
4 transactions
Others Institutions Holding CRL
# of Institutions
692Shares Held
51.7MCall Options Held
259KPut Options Held
463K-
Vanguard Group Inc Valley Forge, PA6.1MShares$995 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$830 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA3.74MShares$610 Million0.13% of portfolio
-
State Street Corp Boston, MA2.13MShares$347 Million0.02% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.94MShares$316 Million0.87% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $8.3B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...